Common pain point
Each 340B covered entity must ensure program integrity and maintain accurate records that comply with program requirements, while also being subject to audit by the manufacturer and the federal government. Studies show more than half of the adverse findings in 2016 HRSA audits are linked to a prescription generated outside the responsibility of the covered entity.
With the eRx Eligibility Check module, covered entities have experienced improved capture rates by combining the Sentrex core data sets with the ePrescription file within Sentry’s 340B solution suite and tightened eligibility checks for prescriptions and patient service locations.
Complete the form below to request a demo and learn more about how Sentry is leading the healthcare intelligence revolution.